Literature DB >> 15728933

Experimental bacteriophage protection against Staphylococcus aureus abscesses in a rabbit model.

Quintin F Wills1, Claire Kerrigan, James S Soothill.   

Abstract

In a rabbit model of wound infection caused by Staphylococcus aureus, 2 x 10(9) PFU of staphylococcal phage prevented abscess formation in rabbits when it was injected simultaneously with S. aureus (8 x 10(7) CFU) into the same subcutaneous site. Phage multiplied in the tissues. Phages might be a valuable prophylaxis against staphylococcal infection.

Entities:  

Mesh：

Year:  2005        PMID： 15728933      PMCID： PMC549253          DOI： 10.1128/AAC.49.3.1220-1221.2005

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  13 in total

1.  Use of lytic bacteriophage for control of experimental Escherichia coli septicemia and meningitis in chickens and calves.

Authors:  P Barrow; M Lovell; A Berchieri
Journal:  Clin Diagn Lab Immunol       Date:  1998-05

2.  Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium.

Authors:  Biswajit Biswas; Sankar Adhya; Paul Washart; Brian Paul; Andrei N Trostel; Bradford Powell; Richard Carlton; Carl R Merril
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

3.  Successful treatment of experimental Escherichia coli infections in mice using phage: its general superiority over antibiotics.

Authors:  H W Smith; M B Huggins
Journal:  J Gen Microbiol       Date:  1982-02

4.  Protective effects of bacteriophage on experimental Lactococcus garvieae infection in yellowtail.

Authors:  T Nakai; R Sugimoto; K H Park; S Matsuoka; K Mori; T Nishioka; K Maruyama
Journal:  Dis Aquat Organ       Date:  1999-06-23       Impact factor: 1.802

5.  Experimental protection of mice against lethal Staphylococcus aureus infection by novel bacteriophage phi MR11.

Authors:  Shigenobu Matsuzaki; Masaharu Yasuda; Hiroshi Nishikawa; Masayuki Kuroda; Takako Ujihara; Taro Shuin; Yuan Shen; Zhe Jin; Shigeyoshi Fujimoto; M D Nasimuzzaman; Hiroshi Wakiguchi; Shigeyoshi Sugihara; Tetsuro Sugiura; Shigeki Koda; Asako Muraoka; Shosuke Imai
Journal:  J Infect Dis       Date:  2003-02-07       Impact factor: 5.226

6.  The control of experimental Escherichia coli diarrhoea in calves by means of bacteriophages.

Authors:  H W Smith; M B Huggins; K M Shaw
Journal:  J Gen Microbiol       Date:  1987-05

7.  Effect of treatment with methicillin and gentamicin in a new experimental mouse model of foreign body infection.

Authors:  F Espersen; N Frimodt-Møller; L Corneliussen; U Riber; V T Rosdahl; P Skinhøj
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

8.  Effectiveness of phages in treating experimental Escherichia coli diarrhoea in calves, piglets and lambs.

Authors:  H W Smith; M B Huggins
Journal:  J Gen Microbiol       Date:  1983-08

9.  Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus.

Authors:  Linda M Weigel; Don B Clewell; Steven R Gill; Nancye C Clark; Linda K McDougal; Susan E Flannagan; James F Kolonay; Jyoti Shetty; George E Killgore; Fred C Tenover
Journal:  Science       Date:  2003-11-28       Impact factor: 47.728

10.  THE MULTIPLICATION OF BACTERIOPHAGE IN VIVO AND ITS PROTECTIVE EFFECT AGAINST AN EXPERIMENTAL INFECTION WITH SHIGELLA DYSENTERIAE.

Authors:  R J Dubos; J H Straus; C Pierce
Journal:  J Exp Med       Date:  1943-09-01       Impact factor: 14.307
View more
  52 in total

1.  Transfersomal Phage Cocktail Is an Effective Treatment against Methicillin-Resistant Staphylococcus aureus-Mediated Skin and Soft Tissue Infections.

Authors:  Sanjay Chhibber; Ashu Shukla; Sandeep Kaur
Journal:  Antimicrob Agents Chemother       Date:  2017-09-22       Impact factor: 5.191

2.  Isolation and characterization of a virulent bacteriophage SPW specific for Staphylococcus aureus isolated from bovine mastitis of lactating dairy cattle.

Authors:  Longping Li; Zhiying Zhang
Journal:  Mol Biol Rep       Date:  2014-07-01       Impact factor: 2.316

Review 3.  Bacteriophages and its applications: an overview.

Authors:  Sonika Sharma; Soumya Chatterjee; Sibnarayan Datta; Rishika Prasad; Dharmendra Dubey; Rajesh Kumar Prasad; Mohan G Vairale
Journal:  Folia Microbiol (Praha)       Date:  2016-10-08       Impact factor: 2.099

4.  Enhanced staphylolytic activity of the Staphylococcus aureus bacteriophage vB_SauS-phiIPLA88 HydH5 virion-associated peptidoglycan hydrolase: fusions, deletions, and synergy with LysH5.

Authors:  Lorena Rodríguez-Rubio; Beatriz Martínez; Ana Rodríguez; David M Donovan; Pilar García
Journal:  Appl Environ Microbiol       Date:  2012-01-20       Impact factor: 4.792

Review 5.  Phage therapy for respiratory infections.

Authors:  Rachel Yoon Kyung Chang; Martin Wallin; Yu Lin; Sharon Sui Yee Leung; Hui Wang; Sandra Morales; Hak-Kim Chan
Journal:  Adv Drug Deliv Rev       Date:  2018-08-07       Impact factor: 15.470

6.  Complete genome sequence of wide-host-range Staphylococcus aureus phage JD007.

Authors:  Zelin Cui; Zhen Song; Yanchun Wang; Lingbin Zeng; Wenbin Shen; Zheng Wang; Qingtian Li; Ping He; Jinhong Qin; Xiaokui Guo
Journal:  J Virol       Date:  2012-12       Impact factor: 5.103

7.  Phage therapy of Pseudomonas aeruginosa infection in a mouse burn wound model.

Authors:  Catherine S McVay; Marisela Velásquez; Joe A Fralick
Journal:  Antimicrob Agents Chemother       Date:  2007-03-26       Impact factor: 5.191

Review 8.  Phage therapy and photodynamic therapy: low environmental impact approaches to inactivate microorganisms in fish farming plants.

Authors:  Adelaide Almeida; Angela Cunha; Newton C M Gomes; Eliana Alves; Liliana Costa; Maria A F Faustino
Journal:  Mar Drugs       Date:  2009-07-30       Impact factor: 5.118

9.  Correlation of Host Range Expansion of Therapeutic Bacteriophage Sb-1 with Allele State at a Hypervariable Repeat Locus.

Authors:  Kirill V Sergueev; Andrey A Filippov; Jason Farlow; Wanwen Su; Leila Kvachadze; Nana Balarjishvili; Mzia Kutateladze; Mikeljon P Nikolich
Journal:  Appl Environ Microbiol       Date:  2019-10-30       Impact factor: 4.792

10.  Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials.

Authors:  Maya Merabishvili; Jean-Paul Pirnay; Gilbert Verbeken; Nina Chanishvili; Marina Tediashvili; Nino Lashkhi; Thea Glonti; Victor Krylov; Jan Mast; Luc Van Parys; Rob Lavigne; Guido Volckaert; Wesley Mattheus; Gunther Verween; Peter De Corte; Thomas Rose; Serge Jennes; Martin Zizi; Daniel De Vos; Mario Vaneechoutte
Journal:  PLoS One       Date:  2009-03-20       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.